{
    "eid": "2-s2.0-84926150868",
    "title": "Pharmacokinetics of Atazanavir/ritonavir among HIV-infected Thai children concomitantly taking tenofovir disoproxil fumarate",
    "cover-date": "2014-01-01",
    "subject-areas": [
        {
            "$": "Microbiology (medical)",
            "@code": "2726"
        },
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        },
        {
            "$": "Pediatrics",
            "@code": "2735"
        }
    ],
    "keywords": [
        "Atazanavir/ritonavir",
        "Pharmacokinetics",
        "Thai HIV-infected children"
    ],
    "authors": [
        "Torsak Bunupuradah"
    ],
    "citedby-count": 6,
    "ref-count": 25,
    "ref-list": [
        "Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial",
        "Adherence and acceptability of once daily lamivudine and abacavir in human immunodeficiency virus type-1 infected children",
        "World Health Organization",
        "Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents",
        "PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection",
        "Reyataz Prescribing Information.",
        "Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of Antiretroviral Agents in Pediatric HIV Infection",
        "A randomised comparison of safety and efficacy of nevirapine vs. atazanavir/ritonavir combined with tenofovir/emtricitabine in treatment-na\u00efve patients",
        "Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: Meta-regression analysis of 12 clinical trials in 5168 patients",
        "Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients",
        "Pharmacokinetics of reduced-dose indinavir/ritonavir 400/100 mg twice daily in HIV-1-infected Thai patients",
        "Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients",
        "Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults",
        "Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children",
        "A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adults",
        "Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection",
        "Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents",
        "Thai national guidelines for the use of antiretroviral therapy in pediatric HIV infection in 2010",
        "Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography",
        "The international interlaboratory quality control program for measurement of antiretroviral drugs in plasma: A global proficiency testing program",
        "Population pharmacokinetics of atazanavir/ritonavir in HIV-1-infected children and adolescents",
        "Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study",
        "Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected adults",
        "Atazanavir plasma concentrations vary significantly between patients and correlate with increased serum bilirubin concentrations",
        "Simultaneous population pharmacokinetic modelling of atazanavir and ritonavir in HIV-infected adults and assessment of different dose reduction strategies"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "affilname": "Mahidol University",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}